无创高频振荡通气与鼻持续气道正压作为早产儿呼吸窘迫综合征初始无创通气模式的比较:多中心前瞻性随机对照试验研究方案
本研究为多中心前瞻性随机对照试验,计划纳入300例胎龄266/7至336/7周、诊断为呼吸窘迫综合征(RDS)的早产儿,随机分为无创高频振荡通气(NHFOV)组或鼻持续气道正压(NCPAP)组,作为初始无创呼吸支持模式。主要结局为入组后7天内需要侵入性机械通气(IMV)的比例,次要结局包括住院天数、无创呼吸支持天数、IMV天数、补充氧疗天数、死亡率、需要肺表面活性物质、严重早产儿视网膜病变需激光或手术、需结扎的动脉导管未闭、支气管肺发育不良、腹胀、气漏综合征、脑室内出血(≥3级)、自发性肠穿孔、坏死性小肠结肠炎(≥II期)和鼻部损伤,以及矫正年龄18-24月龄时的Bayley婴儿发育量表评分。
要点
- NHFOV作为初始无创通气模式与NCPAP比较,主要看7天内需IMV的比例。
- 纳入胎龄266/7至336/7周、诊断RDS的早产儿300例,多中心随机分组。
- 次要结局涵盖BPD、死亡、气漏、NEC、IVH等及18-24月龄神经发育。
核心结论
- 该试验旨在评估NHFOV作为初始无创通气模式能否减少早产儿RDS对IMV的需求及相关并发症。
研究设计与样本
- 多中心前瞻性随机对照试验,计划纳入300例胎龄266/7至336/7周、诊断RDS的早产儿,在中国18个三级新生儿重症监护病房进行。
- 随机分为NHFOV组或NCPAP组,作为初始无创呼吸支持模式。
关键数值与推荐
- 主要结局为入组后7天内需要IMV。
- 预设次要结局包括住院天数、无创呼吸支持天数、IMV天数、补充氧疗天数、死亡率、需要肺表面活性物质、严重早产儿视网膜病变需激光或手术、需结扎的动脉导管未闭、支气管肺发育不良、腹胀、气漏综合征、脑室内出血(≥3级)、自发性肠穿孔、坏死性小肠结肠炎(≥II期)和鼻部损伤。
- 其他次要结局包括矫正年龄18-24月龄时的Bayley婴儿发育量表评分。
临床怎么用
- 若试验证实NHFOV作为初始模式可减少IMV需求,可能为早产儿RDS提供新的无创呼吸支持选择。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Invasive mechanical ventilation (IMV) is associated with the development of adverse pulmonary and non-pulmonary outcomes in very premature infants. Various modes of non-invasive respiratory support are increasingly being used to decrease the incidence of bronchopulmonary dysplasia. The aim of this trial is to compare the effect of non-invasive high-frequency oscillatory ventilation (NHFOV) and nasal continuous positive airway pressure (NCPAP) in preterm infants with respiratory distress syndrome (RDS) as a primary non-invasive ventilation support mode. METHODS/DESIGN: In this multi-center randomized controlled trial, 300 preterm infants born at a gestational age of 266/7 to 336/7 weeks with a diagnosis of RDS will be randomized to NHFOV or NCPAP as a primary mode of non-invasive respiratory support. The study will be conducted in 18 tertiary neonatal intensive care units in China. The primary outcome is the need for IMV during the first 7 days after enrollment in preterm infants randomized to the two groups. The prespecified secondary outcomes include days of hospitalization, days on non-invasive respiratory support, days on IMV, days on supplemental oxygen, mortality, need for a surfactant, severe retinopathy of prematurity requiring laser treatment or surgery, patent ductus arteriosus needing ligation, bronchopulmonary dysplasia, abdominal distention, air leak syndromes, intraventricular hemorrhage (≥ grade 3), spontaneous intestinal perforation, necrotizing enterocolitis (≥II stage), and nasal trauma. Other secondary outcomes include Bayley Scales of Infant Development at 18-24 months of corrected age. DISCUSSION: In recent decades, several observational studies have compared the effects of NHFOV and NCPAP in neonates as a rescue mode or during weaning from IMV. To our knowledge, this will be the first multi-center prospective, randomized controlled trial to evaluate NHFOV as a primary mode in preterm infants with RDS in China or any other part of the world. Our trial may help to establish guidelines for NHFOV in preterm infants with RDS to minimize the need for IMV, and to decrease the significant pulmonary and non-pulmonary morbidities associated with IMV. TRIAL REGISTRATION: ClinicalTrials.gov, NCT03099694 . Registered on 4 April 2017.
引用
- Zhu XW, Shi Y, Shi LP, et al. Non-invasive high-frequency oscillatory ventilation versus nasal continuous positive airway pressure in preterm infants with respiratory distress syndrome: Study protocol for a multi-center prospective randomized controlled trial. Trials. 2018. PMID: 29898763. doi:10.1186/s13063-018-2673-9
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。